Abstract
Human immunodeficiency virus (HIV)-associated nephropathy (HIVAN) is most frequently seen as a late manifestation in adult patients with a high viral load and low T-helper cell (CD4) counts. We report a case of HIVAN in a black Zimbabwean teenager in whom the disease activity was well suppressed for years following highly active antiretroviral therapy (HAART). Proteinuria was absent at 9 years of age when he presented with vertically transmitted HIV infection. Within a few months of HAART, the viral load became undetectable and CD4 count was normalised. Nephrotic range proteinuria, with preserved renal function, developed approximately 4 years later despite excellent HIV disease suppression. Renal biopsy showed non-collapsing focal segmental glomerular sclerosis changes compatible with HIVAN. Although the role of other unknown factors in the disease pathogenesis could not be totally excluded, this case demonstrates that HIVAN can still occur in HIV-infected children despite excellent HAART and that the disease manifestations and outcome may differ from those reported in previous studies.
References
Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA (2005) Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40:1559–1585
Ray PE, Rakusan T, Loechelt BJ, Selby DM, Liu XH, Chandra RS (1998) Human immunodeficiency virus (HIV)-associated nephropathy in children from the Washington, D.C. area: 12 years' experience. Semin Nephrol 18:396–405
Strauss J, Abitbol C, Zillerruelo G, Scott G, Paredes A, Malaga S, Montane B, Mitchell C, Parks W, Pardo V (1989) Renal disease in children with acquired immunodeficiency syndrome. N Engl J Med 321:625–630
Winston JA, Burns GC, Klotman PE (1998) Human immunodeficiency virus (HIV) epidemic and HIV associated nephropathy. Semin Nephrol 18:373–377
Ahuja TS, Abbott KC, Pack L, Kuo YF (2004) HIV-associated nephropathy and end-stage renal disease in children in the United States. Pediatr Nephrol 19:808–811
Winston JA, Klotman ME, Klotman PE (1999) HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 55:1036–1040
Izzedine H, Wirden M, Launay-Vacher V (2005) Viral load and HIV-associated nephropathy. N Engl J Med 353:1072–1074
Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, Winston JA (2004) The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66:1145–1152
Gavin PJ, Yogev R (2002) The role of protease inhibitor therapy in children with HIV infection. Paediatr Drugs 4:581–607
D’Agati V, Appel GB (1998) Renal pathology of human immunodeficiency virus infection. Semin Nephrol 18:406–421
D’Agati V, Suh JI, Carbone L, Cheng JT, Appel G (1989) Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 35:1358–1370
Wyatt CM, Morgello S, Katz-Malamed R, Wei C, Klotman ME, Klotman PE, D'Agati VD (2009) The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int 75:428–434
Ray PE (2009) Taking a hard look at the pathogenesis of childhood HIV-associated nephropathy. Pediatr Nephrol 24:2109–2119
Albaqumi M, Soos TJ, Barisoni L, Nelson PJ (2006) Collapsing glomerulopathy. J Am Soc Nephrol 17:2854–2863
Wyatt CM, Klotman PE, D'Agati VD (2008) HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. Semin Nephrol 28:513–522
McElrath MJ, Pruett JE, Cohn ZA (1989) Mononuclear phagocytes of blood and bone marrow: Comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc Natl Acad Sci USA 86:675–679
Wong JK, Gunthard HF, Havlir DV, Zhang ZQ, Haase AT, Ignacio CC, Kwok S, Emini E, Richman DD (1997) Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci USA 94:12574–12579
Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, Klotman PE (2000) Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 11:2079–2087
Winston JA, Bruggeman LA, Ross MD, Jacobson J, Ross L, D'Agati VD, Klotman PE, Klotman ME (2001) Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344:1979–1984
Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM, Cara A, Ross MD, Gusella GL, Benson G, D'Agati VD, Hahn BH, Klotman ME, Klotman PE (2002) Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 8:522–526
Cantor ES, Kimmel PL, Bosch JP (1991) Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 151:125–128
Ray PE, Tassi E, Liu XH, Wellstein A (2006) Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome. Am J Physiol Regul Integr Comp Physiol 290:R105–R113
Izzedine H, Deray G (2007) The nephrologist in the HAART era. AIDS 21:409–421
McCulloch MI, Ray PE (2008) Kidney disease in HIV-positive children. Semin Nephrol 28:585–594
Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Porter K, Walker AS, Collaboration CASCADE (2003) Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 362:1267–1274
Gibb DM, Duong T, Tookey PA, Sharland M, Tudor-Williams G, Novelli V, Butler K, Riordan A, Farrelly L, Masters J, Peckham CS, Dunn DT, NSHPC and CHIPS study (2003) Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. Br Med J 327:1019–1031
Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE (2005) Highly active antiretroviral therapy and the epidemic of HIV + end-stage renal disease. J Am Soc Nephrol 16:2412–2420
Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD (2004) Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 18:541–546
Kirchner JT (2002) Resolution of renal failure after initiation of HAART: 3 cases and a discussion of the literature. AIDS Read 12(103–105):110–112
Wali RK, Drachenberg CI, Papadimitriou JC, Keay S, Ramos E (1998) HIV-1-associated nephropathy and response to highly active antiretroviral therapy. Lancet 352:783–784
Chaparro A, Mitchell C, Abitbol C, Wilkinson J, Baldarrago G, Lopez E, Zilleruelo G (2008) Proteinuria in Children Infected with the Human Immunodeficiency Virus. J Pediatr 152:844–849
Han TM, Naicker S, Ramdial RK, Assounga AG (2006) A cross-sectional study of the HIV- seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 69:2243–2250
Smith MC, Austen JL, Carey JT, Emancipator SN, Herbener T, Gripshover B, Mbanefo C, Phinney M, Rahman M, Salata RA, Weigel K, Kalayjian RC (1996) Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med 101(1):41–48
Wei A, Burns GC, Williams BA, Mohammed NB, Visintainer P, Sivak SL (2003) Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int 64(4):1462–1471
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hegde, S., Singh, C. & Óhare, B. HIV-associated nephropathy in the setting of maximal virologic suppression. Pediatr Nephrol 26, 973–977 (2011). https://doi.org/10.1007/s00467-011-1783-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-011-1783-3